SML2182

Succinobucol

≥98% (HPLC)

• Sinónimos: AGI-1067, Butanedioic acid 1-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenyl]ester, Probucol monosuccinate
• Fórmula empírica (notación de Hill): C₃₅H₅₂O₅S₂
• Número CAS: 216167-82-7
• Peso molecular: 616.91
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD08690469
• Assay: ≥98% (HPLC)
• Form: powder

Propiedades

• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• SMILES string: OC1=C(C(C)(C)C)C=C(SC(C)(C)SC2=CC(C(C)(C)C)=C(OC(CCC(O)=O)=O)C(C(C)(C)C)=C2)C=C1C(C)(C)C
• InChI: 1S/C35H52O5S2/c1-31(2,3)23-17-21(18-24(29(23)39)32(4,5)6)41-35(13,14)42-22-19-25(33(7,8)9)30(26(20-22)34(10,11)12)40-28(38)16-15-27(36)37/h17-20,39H,15-16H2,1-14H3,(H,36,37)
• InChI key: RKSMVPNZHBRNNS-UHFFFAOYSA-N

Descripción

Biochem/physiol Actions

Orally active antioxidant; vascular protectant; antiatherosclerotic;

Succinobucol is a metabolically stable derivative of the antioxidant drug probucol that poses a distinct pharmacological from. Succinobucol is an orally active vascular protectant that exhibits antiatherosclerotic properties in multiple animal models and in humans. It inhibits the release of proinflammatory cytokines, TNF-a, IL-1b, and IL-6 in hPBMC activated by LPS.

Información de seguridad

• Clase de almacenamiento: 11 - Combustible Solids
• wgk: WGK 3